New York, NY (PRWEB) March 05, 2014
The prescription drug safety center DrugRisk.com is announcing new information on the site for patients using testosterone replacement therapy drugs. The FDA was recently petitioned to add warnings to the drug labels* after studies and lawsuits alleged they may cause heart attacks or stroke**.
DrugRisk was created to provide those using popular prescription drugs with the latest warnings, safety alerts, product recalls and litigation news. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
Last year, more than 5.5 million men filled prescriptions for low-T drugs like AndroGel, Axiron and AndroDerm***. However, recent studies question their safety.
DrugRisk has added a study from UCLA and the National Institutes of Health and UCLA showing those over 65 or with a history of heart disease using low-T drugs had double the rate of heart attack****. Last year, the AMA released data showing the same patients also had a 29% increased rate of heart attacks, stroke or death from low-T drugs*****.
The FDA recently advised it would start a new investigation into testosterone drug safety due to the studies******.
Now, the resource center has learned the FDA was also petitioned by the consumer advocates at Public Citizen to add label warnings for cardiac risks in low-T drugs, citing the recent studies and as many as 13,000 prescriptions each day*.
Some patients have already filed a testosterone lawsuit in federal court alleging AndroGel caused heart attack or stroke without warning**. Lawyers are offering help to those affected.
Anyone who suffered a heart attack, stroke or cardiovascular event after using a low-T drug like AndroGel, Axiron or AndroDerm is urged to visit DrugRisk or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers who have already handled testosterone lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*Reuters, 2/25/14; reuters.com/article/2014/02/25/us-testosterone-heart-risk-idUSBREA1O11A20140225
**Bloomberg, 2/5/14; bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html; Aurecchia v. AbbVie Inc., 14-cv-00772, U.S. Dist. Ct, Northern District of Illinois (Chicago); Marino v. AbbVie Inc., 14-cv-00777 U.S. Dist. Ct, Northern District of Illinois (Chicago)
***Bloomberg, 1/31/14; bloomberg.com/news/2014-01-31/heart-attack-risk-of-testosterone-drugs-under-u-s-review.html
****Public Library of Science, 1/29/14; plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
*****JAMA 11/5/13; media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/
******FDA, 1/31/14; http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery